GDF-8 Pre-Mixed Peptide
+99% Purity cGMP Certified COA Every Batch
Pre-Mixed Peptide

GDF-8 Pre-Mixed Peptide

4.9 (47 reviews)

Stackpure provides GDF-8 Pre-Mixed Peptide for myostatin pathway characterisation, sarcopenia modelling, and inhibitor validation research. This research-grade pre-mixed peptide is Myostatin (GDF-8) itself, used as a research tool to model myostatin activity, study inhibitor potency, or induce muscle atrophy in pre-clinical models. Produced to +99% purity (HPLC verified), cGMP-certified, with a Certificate of Analysis available every batch.

For in vitro research use only. Not for human consumption. Not approved by the FDA. Not a drug, medicine, or supplement.

In Stock · Ships 1–3 days
$114.41
USD · Research pricing
1
Build a Stack
Format Pre-Mixed Peptide
Purity +99% (HPLC verified)
Certification cGMP-certified facility
Certificate COA every batch, see testing standards on the Lab Testing page →
Certificate of Analysis, every batch
Product GDF-8 Pre-Mixed Peptide
Analytical Method HPLC / ESI-MS
Purity Standard +99%
Testing Party Independent third-party lab

Your batch's actual Certificate of Analysis is available on request with your order and batch number, usually within 24 hours. Full testing standards on the Lab Testing page.

GDF-8 Pre-Mixed Peptide is a research-grade pre-mixed peptide supplied by Stackpure for laboratory investigation. GDF-8 is studied in the context of athletic performance, muscle hypertrophy, and physical endurance. Each unit is manufactured in a cGMP-certified facility and verified to +99% purity by HPLC analysis before dispatch.

What Is GDF-8?

GDF-8 is a compound that has attracted significant interest in preclinical research examining athletic performance, muscle hypertrophy, and physical endurance. Scientists investigating GDF-8 have worked to characterise its mechanisms, receptor interactions, and downstream biological effects across multiple in vitro and animal model systems.

Stackpure provides GDF-8 Pre-Mixed Peptide for researchers requiring verified, traceable material. The pre-mixed format arrives ready for immediate use, reducing preparation time in active research environments. Researchers may also be interested in GDF-8 Nasal Spray, which provides the same compound in an alternative format.

this pre-mixed peptide Research Applications

Preclinical studies involving this pre-mixed peptide have explored the following areas:

  • Growth hormone axis: Research has examined interactions with GHRP and GHRH pathways, with implications for GH pulsatility studies.
  • Lean mass research: Preclinical investigations have explored anabolic signalling and protein synthesis pathways relevant to muscle biology.
  • Endurance and fatigue: Studies have assessed mitochondrial efficiency and oxidative capacity in models of prolonged physical exertion.

These directions reflect the broad scientific interest in GDF-8 and the growing body of literature examining its potential applications in research contexts.

Stackpure's pre-mixed peptide Quality Standards

Every this pre-mixed peptide supplied by Stackpure is held to rigorous analytical standards. Researchers choosing Stackpure pre-mixed peptide receive material that has been independently verified for identity, purity, and potency. Quality documentation includes a Certificate of Analysis (COA) for every production batch, providing full analytical transparency.

  • Purity: +99% by HPLC analysis
  • Facility: cGMP-certified manufacturing
  • Testing: Identity, purity, and potency verified per batch
  • Documentation: COA available for every order

This analytical rigour ensures that researchers working with Stackpure's pre-mixed peptide can maintain experimental consistency and reproducibility across studies.

Research Use Disclaimer

Independent Lab Verification

Stackpure works with independent, accredited third-party laboratories, including Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), to verify compound identity and purity. A Certificate of Analysis is included with every order.

this pre-mixed peptide from Stackpure is supplied strictly for in vitro research and laboratory purposes. This material is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any condition. All research involving this pre-mixed peptide must be conducted in accordance with applicable institutional, ethical, and regulatory guidelines. For research use only.

Working with the pre-mixed solution

  • Supplied already dissolved in solution, which removes the reconstitution step and the dilution error that comes with it.
  • The concentration is fixed at manufacture, so volumes are calculated directly from the label.
  • Keep refrigerated and protected from light. Avoid repeated warming and cooling of the vial.
  • Best suited to protocols that need consistency from one preparation to the next.

Other formats of GDF-8

FormatPrice (USD)
GDF-8 Peptide Vial $80.11 View
GDF-8 Nasal Spray $87.38 View

Research Questions

What is GDF-8 Pre-Mixed Peptide used for in research?

this pre-mixed peptide is a research-grade pre-mixed peptide studied for myostatin pathway characterisation, sarcopenia modelling, and inhibitor validation research. It acts as Myostatin (GDF-8) itself, used as a research tool to model myostatin activity, study inhibitor potency, or induce muscle atrophy in pre-clinical models. All findings are from pre-clinical in vitro and animal studies; it is not approved for human use.

How does GDF-8 Pre-Mixed Peptide work?

this pre-mixed peptide is Myostatin (GDF-8) itself, used as a research tool to model myostatin activity, study inhibitor potency, or induce muscle atrophy in pre-clinical models. This mechanism has been characterised in multiple pre-clinical studies, with particular focus on myostatin pathway characterisation outcomes.

What research dosage is used for GDF-8 Pre-Mixed Peptide?

Pre-clinical models use 0.1–1 mg/kg to induce measurable muscle atrophy over 14–28 days. All dosage information is from pre-clinical or research contexts only. this pre-mixed peptide is sold exclusively for research use and is not approved for human consumption.

How does GDF-8 Pre-Mixed Peptide compare to related research compounds?

this pre-mixed peptide is frequently studied alongside ACE-031 and Follistatin-344 as functional antagonists in the same research pathway. Its myostatin (GDF-8) classification distinguishes its mechanism from these alternatives, making it suitable for pathway-specific research protocols.

Where can I buy GDF-8 Pre-Mixed Peptide for research purposes?

Stackpure supplies this pre-mixed peptide as a research-grade pre-mixed peptide with +99% purity (HPLC verified), cGMP certification, and a Certificate of Analysis. Orders ship to the US, UK, Canada, and Australia. It is sold for in vitro research use only.

What does the Certificate of Analysis verify for GDF-8 Pre-Mixed Peptide?

A Certificate of Analysis (COA) reports identity (confirming the compound is what it's labeled as, via HPLC-UV/VIS matched against a reference standard) and assay/content (the measured purity percentage). this pre-mixed peptide is tested through independent third-party laboratory analysis, including work performed by Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), which is what verifies a batch matches its labeled specification rather than relying on a purity claim alone.